Literature DB >> 24066892

Immune senescence and vaccination in the elderly.

Pierre Olivier Lang1, Sheila Govind, Annemieke Ten Bokum, Natalie Kenny, Emmanuel Matas, David Pitts, Richard Aspinall.   

Abstract

Vaccines are powerful public health tools that have been of tremendous benefit in protecting vulnerable populations worldwide from many pathogens. However, vaccine- preventable diseases still remain a considerable burden and this is particularly true among aging and aged populations in industrialized countries. The predicted demographic shift in the population landscape towards an ever-increasing aging population and the evidence suggesting that older individuals mount less-than optimal immune response to vaccination have raised the question of improving vaccine responses in older individuals. This review presents recent progress in the understanding at the cellular and molecular levels of age related immune decline and strategies to translate current knowledge into the development of immunization strategies to promote healthy aging, keeping older members of our society autonomous and independent.

Mesh:

Substances:

Year:  2013        PMID: 24066892     DOI: 10.2174/15680266113136660181

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  15 in total

1.  Preexisting Immunity, Not Frailty Phenotype, Predicts Influenza Postvaccination Titers among Older Veterans.

Authors:  Puja Van Epps; Terrence Tumpey; Melissa B Pearce; Hana Golding; Patricia Higgins; Thomas Hornick; Christopher Burant; Brigid M Wilson; Richard Banks; Stefan Gravenstein; David H Canaday
Journal:  Clin Vaccine Immunol       Date:  2017-03-06

2.  Toward a human vaccines project.

Authors:  Wayne C Koff; Ian D Gust; Stanley A Plotkin
Journal:  Nat Immunol       Date:  2014-07       Impact factor: 25.606

Review 3.  Vaccination in the elderly: what can be recommended?

Authors:  Pierre-Olivier Lang; Richard Aspinall
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

4.  Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant.

Authors:  Junli Li; Lili Fu; Yang Yang; Guozhi Wang; Aihua Zhao
Journal:  Vaccines (Basel)       Date:  2022-03-29

5.  Age-Related Decline in Natural IgM Function: Diversification and Selection of the B-1a Cell Pool with Age.

Authors:  Nichol E Holodick; Teresa Vizconde; Thomas J Hopkins; Thomas L Rothstein
Journal:  J Immunol       Date:  2016-04-20       Impact factor: 5.422

Review 6.  Can we translate vitamin D immunomodulating effect on innate and adaptive immunity to vaccine response?

Authors:  Pierre Olivier Lang; Richard Aspinall
Journal:  Nutrients       Date:  2015-03-20       Impact factor: 5.717

7.  Age-related differences in polyfunctional T cell responses.

Authors:  Puja Van Epps; Richard Banks; Htin Aung; Michael R Betts; David H Canaday
Journal:  Immun Ageing       Date:  2014-10-23       Impact factor: 6.400

8.  Effectiveness of seasonal influenza vaccination in patients with diabetes: protocol for a nested case-control study.

Authors:  Ludovic Casanova; Sébastien Cortaredona; Jean Gaudart; Odile Launay; Philippe Vanhems; Patrick Villani; Pierre Verger
Journal:  BMJ Open       Date:  2017-08-18       Impact factor: 2.692

9.  Inverse relationship between serum vitamin D level and measles antibody titer: A cross-sectional analysis of NHANES, 2001-2004.

Authors:  Yi-Hsien Chen; Wei-Ming Wang; Tung-Wei Kao; Chien-Ping Chiang; Chih-Tsung Hung; Wei-Liang Chen
Journal:  PLoS One       Date:  2018-11-30       Impact factor: 3.240

10.  Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer.

Authors:  Tal Goshen-Lago; Ithai Waldhorn; Roy Holland; Moran Szwarcwort-Cohen; Anat Reiner-Benaim; Yael Shachor-Meyouhas; Khetam Hussein; Liana Fahoum; Mali Baruch; Avivit Peer; Yoram Reiter; Ronit Almog; Michael Halberthal; Irit Ben-Aharon
Journal:  JAMA Oncol       Date:  2021-07-08       Impact factor: 31.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.